Dutch medtech startup InnoSIGN completes spin-out from Philips with €7.33M Series…
InnoSIGN commercialises its proprietary mRNA-based OncoSIGNal pathway activity profiling technology, to revolutionise precision medicine by obtaining more insight into the mechanisms of disease.